BerandaRLFTF • OTCMKTS
add
RELIEF THERAPEUTICS Holding SA
Tutup sebelumnya
$3,78
Rentang hari
$3,70 - $3,86
Rentang tahun
$1,10 - $7,66
Kapitalisasi pasar
47,88Â jt CHF
Volume Rata-Rata
3,94Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
SWX
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CHF) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,83Â jt | 87,03% |
Biaya operasional | 4,04Â jt | -41,31% |
Laba bersih | -2,28Â jt | 91,93% |
Margin laba bersih | -80,60 | 95,69% |
Penghasilan per saham | — | — |
EBITDA | -1,27Â jt | 74,88% |
Tarif pajak efektif | -14,01% | — |
Neraca
Total aset
Total liabilitas
| (CHF) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 10,73Â jt | -16,20% |
Total aset | 70,92Â jt | -43,61% |
Total liabilitas | 21,65Â jt | -31,07% |
Total ekuitas | 49,27 jt | — |
Saham yang beredar | 12,55 jt | — |
Harga terhadap nilai buku | 0,96 | — |
Tingkat pengembalian aset | -7,01% | — |
Tingkat pengembalian modal | -9,62% | — |
Arus Kas
Perubahan kas bersih
| (CHF) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -2,28Â jt | 91,93% |
Kas dari operasi | -1,58Â jt | 69,75% |
Kas dari investasi | -3,50Â rb | 96,82% |
Kas dari pembiayaan | -308,00Â rb | -114,76% |
Perubahan kas bersih | -1,91Â jt | 40,61% |
Arus kas bebas | -635,56Â rb | 75,84% |
Tentang
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Didirikan
2013
Karyawan
36
